Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

BLOOD ADVANCES

ELSEVIER

1. School of Oncology of German Cancer Consortium (DKTK)
2. Else Kroner Forschungskolleg
3. Deutsche Forschungsgemeinschaft (DFG
4. German Research Foundation) [SFB-TRR 388/1 2021-452881907, 451580403]
5. Bavarian Elite Graduate Training Network
6. WilhelmSander Stiftung [2018.087.1]
7. Else-KronerFresenius Stiftung
8. Bavarian Center for Cancer Research (BZKF)